Page last updated: 2024-11-06

prednisolone and Maxillary Neoplasms

prednisolone has been researched along with Maxillary Neoplasms in 2 studies

Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.

Maxillary Neoplasms: Cancer or tumors of the MAXILLA or upper jaw.

Research Excerpts

ExcerptRelevanceReference
"A case of osteogenic sarcoma of the maxilla is described."1.26Chemotherapy in the treatment of osteogenic sarcoma of the maxilla (case report). ( Nakajima, T; Yokobayashi, T, 1978)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yokobayashi, T1
Nakajima, T1
Bollobás, B1

Other Studies

2 other studies available for prednisolone and Maxillary Neoplasms

ArticleYear
Chemotherapy in the treatment of osteogenic sarcoma of the maxilla (case report).
    Journal of maxillofacial surgery, 1978, Volume: 6, Issue:4

    Topics: Alkaline Phosphatase; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Maxillary Neoplasms;

1978
[Our experience with endoscopy of the facial sinuses].
    Wiener medizinische Wochenschrift (1946), 1966, Feb-26, Volume: 116, Issue:9

    Topics: Anti-Bacterial Agents; Cysts; Diagnosis, Differential; Edema; Endoscopy; Humans; Maxillary Fractures

1966